Orin
LITENasdaq·Communication Equipment

Lumentum Holdings Inc. LITE

Market cap $71.9BP/E no earnings to divide byGross margin 41.7%Reports Tue 3 Nov, after the close
$923.94
−13.06 (−1.39%)live 09:30 ET
52-wk $144.52 – $1085.68
Watch
Orin's take
0.62conviction · moderate
Refreshed 17 Aug · take v7. A new filing or a print queues the next refresh.

Lumentum's AI-driven optics inflection is undeniable: FY2026 revenue nearly doubled to $3.01B with operating income swinging to $524.8M from a $192.2M loss, and Q1 FY2027 guidance of ~$4.20 EPS midpoint implies the growth trajectory is accelerating. However, the stock at $968.90 trades at 23.9x trailing P/S — roughly 4x the peer median of 6.0x — while FY2026 GAAP net income was a catastrophic -$6.94B (EPS -$92.96), likely reflecting a massive non-cash impairment, and insiders have net sold $91.6M over 24 months.

The growth story is working, but the valuation prices in near-flawless execution and leaves no margin for error.

What could go wrong

  • Valuation compression. At 23.9x P/S vs peer median 6.0x, any deceleration in the AI optics ramp or guide-down could trigger a sharp multiple contraction given the stock already trades 51% above its 50-day MA and 51% above its 200-day MA.
  • Massive GAAP net loss. FY2026 net income of -$6.94B (EPS -$92.96) against $524.8M operating income signals a large non-operating charge — possibly a goodwill impairment — that raises questions about asset quality and the durability of reported equity value.
  • Insider distribution. Insiders net sold $91.6M over 24 months with 138 dispositions vs 41 acquisitions; recent sales at $868–$1,000/share suggest management is monetizing the rally rather than accumulating.
  • Customer concentration / AI capex cyclicality. The growth is concentrated in components for AI data center optics; any slowdown in hyperscaler capex or technology transition risk (e.g., competing interconnect standards) could materially impact the ramp.

What would change my mind

Q1 FY2027 print vs guidance. Revenue and EPS relative to the ~$1.25B / ~$4.20 midpoint guide; a beat-and-raise confirms the ramp, a miss or guide-down breaks the thesisbullish
Gross margin trajectory. Non-GAAP gross margin sustaining or expanding above 50% (Q4 was 50.4% per prior verdict) would support the premium; compression below 45% would signal pricing pressurebullish
Insider buying reversal. Meaningful open-market insider purchases (not just 108-share board grants) would signal confidence at these levels; continued selling at $950+ would be bearishbullish
GAAP profitability normalization. Clarification of the -$6.94B net loss driver and return to GAAP profitability in FY2027 would reduce uncertainty; recurring non-cash charges would be bearishbullish

Where this comes from: FMP annual fundamentals FY2026 · FMP annual fundamentals FY2025 · peer_relative composite · insider summary 24-month window. Orin's read on LITE; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Capital Management$4.4B0.1% of fund
Vanguard Portfolio Management$3.5B0.2% of fund
Jpmorgan Chase &$3.5B0.2% of fund
Fmr$3.0B0.1% of fund
State Street$3.0B0.1% of fund
Invesco$2.7B0.2% of fund

129 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 275 Form 4 filings, net −$311.3M. Of the 50 on hand, 0 were open-market purchases and 45 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about LITE

its filings · its transcripts · its numbers

Orin answers questions about LITE from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

vs its own 5y · Technology
MetricNowOwn medianSector
P/S24.19×3.24×
P/B15.1×3.0×

Its P/E sits 20th percentile of its own last 5 years (−0.64σ from its own mean).

What the price assumes

42.9%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $0.3B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

25 firms · 2026-09-23
Consensus target

$1092

$820$1270 · +18% against today's price

How they rate it
  • 18 buy or overweight
  • 7 hold
  • 0 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 35.3× of 4 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
LITELumentum Holdings Inc.$73B41.7%-230.1%-300%
ENTGEntegris, Inc.$23B75.5×30.5×45.5%9.2%8%
FFIVF5, Inc.$26B35.9×25.3×82.2%22.0%20%
FNFabrinet$14B30.3×25.3×12.0%10.2%21%
ZBRAZebra Technologies Corporation$18B34.7×17.8×48.9%9.2%15%

The median is of the 4 peers listed above and nothing else — check it against the column. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY18 14.9×FY25 249.3×

What its sector has traded at

Technology
FY14 9.0×FY26 48.0×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$-16$851.84 · −102%2026-06-10
Levered DCF$-6$851.84 · −101%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $923.94
52-week range$145 – $1086
Analyst targets$820 – $1270
Standard DCF$-16 as of 2026-06-10, when it was $851.84
Levered DCF$-6 as of 2026-06-10, when it was $851.84

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.